The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Regorafenib in antiangiogenic-naive, chemotherapy-refractory advanced colorectal cancer: A phase IIb trial.
 
Rachel Pimenta Riechelmann
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; SERVIER
 
Luiz Antonio Senna Leite
No Relationships to Disclose
 
Joao Glasberg
No Relationships to Disclose
 
Giovanni Mendonca Bariani
No Relationships to Disclose
 
Thomas Giollo Rivelli
No Relationships to Disclose
 
Daniela R. Nebuloni
No Relationships to Disclose
 
Fabiola Puty
Employment - Bayer
 
Christian Kappeler
Employment - Bayer
 
Kaline M. C. Pereira
Employment - Bayer
 
Marcelo A Queiroz
No Relationships to Disclose
 
Paulo Marcelo Hoff
Consulting or Advisory Role - AstraZeneca (I); Bayer (I)
Research Funding - Roche/Genentech